INH6 is primarily utilized in the field of biomedical research, particularly in studies related to cancer therapy. It functions as an inhibitor targeting specific pathways involved in tumor growth and proliferation. Researchers employ INH6 to investigate its potential in suppressing cancer cell survival and enhancing the efficacy of existing treatments. Its application extends to preclinical studies where it is used to understand molecular mechanisms and evaluate therapeutic outcomes in various cancer models. Additionally, INH6 is explored for its role in combination therapies, aiming to improve treatment strategies for resistant or aggressive cancers.